AAAAAA

   
Results: 1-9 |
Results: 9
Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?
Authors: Vandel, P Haffen, E Vandel, S Bonin, B Sechter, D Bizouard, P Dalery, J
Citation: P. Vandel et al., Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?, THERAPIE, 55(3), 2000, pp. 349-353
Plasma levels of clozapine and desmethylclozapine are unaffected by concomitant ingestion of grapefruit juice
Authors: Vandel, S Netillard, C Perault, MC Bel, AM
Citation: S. Vandel et al., Plasma levels of clozapine and desmethylclozapine are unaffected by concomitant ingestion of grapefruit juice, EUR J CL PH, 56(4), 2000, pp. 347-348
Influence of CYP2D62 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?
Authors: Haffen, E Vandel, P Paintaud, G Broly, F Vandel, S Bonin, B Bizouard, P Sechter, D Bechtel, PR
Citation: E. Haffen et al., Influence of CYP2D62 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?, EUR J CL PH, 55(11-12), 2000, pp. 877-879
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype
Authors: Haffen, E Vandel, P Broly, F Vandel, S Sechter, D Bizouard, P Bechtel, PR
Citation: E. Haffen et al., Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype, PHARMACOPS, 32(6), 1999, pp. 232-234
Citalopram pharmacokinetic interaction with clomipramine. UDP-glucuronosyltransferase inhibition? A case report
Authors: Haffen, E Vandel, P Bonin, B Vandel, S
Citation: E. Haffen et al., Citalopram pharmacokinetic interaction with clomipramine. UDP-glucuronosyltransferase inhibition? A case report, THERAPIE, 54(6), 1999, pp. 768-770
Lack of adverse reaction when switching SSRIs to NASSRIs in polymedicated depressed inpatients
Authors: Haffen, E Vandal, P Regina, W Vandel, S
Citation: E. Haffen et al., Lack of adverse reaction when switching SSRIs to NASSRIs in polymedicated depressed inpatients, THERAPIE, 54(2), 1999, pp. 267-269
Seratonin syndrome after sertraline, buspirone and loxapine?
Authors: Bonin, B Vandel, P Vandel, S Sechter, D Bizouard, P
Citation: B. Bonin et al., Seratonin syndrome after sertraline, buspirone and loxapine?, THERAPIE, 54(2), 1999, pp. 269-271
Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypes
Authors: Vandel, P Haffen, E Vandel, S Bonin, B Nezelof, S Sechter, D Broly, F Bizouard, P Dalery, J
Citation: P. Vandel et al., Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypes, EUR J CL PH, 55(9), 1999, pp. 659-665
Fluvoxamine and convulsive syncope: a case report
Authors: Regina, W Vandel, S
Citation: W. Regina et S. Vandel, Fluvoxamine and convulsive syncope: a case report, THERAPIE, 53(5), 1998, pp. 504-505
Risultati: 1-9 |